Effect of insulin-like growth factor-1 (IGF-1) plus alendronate on bone density during puberty in IGF-1-deficient MIDI mice (Q31070867)

28 June 2017

title

Effect of insulin-like growth factor-1 (IGF-1) plus alendronate on bone density during puberty in IGF-1-deficient MIDI mice (English)

1 reference

28 June 2017

1 reference

Stabnov L

1 reference

28 June 2017

Kasukawa Y

1 reference

28 June 2017

Guo R

1 reference

28 June 2017

Amaar Y

1 reference

28 June 2017

Wergedal JE

1 reference

28 June 2017

Baylink DJ

1 reference

28 June 2017

Mohan S

1 reference

28 June 2017

publication date

1 June 2002

1 reference

28 June 2017

1 reference

28 June 2017

1 reference

28 June 2017

1 reference

28 June 2017

page(s)

909-916

1 reference

A controlled study of the effects of alendronate in a growing mouse model of osteogenesis imperfecta

28 June 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2802%2900738-X

7 January 2021

The potentiation of estrogen on insulin-like growth factor I action in MCF-7 human breast cancer cells includes cell cycle components

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2802%2900738-X

7 January 2021

Treatment of post-menopausal osteoporosis with a combination of growth hormone and pamidronate: a placebo controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2802%2900738-X

7 January 2021

One year of insulin-like growth factor I treatment does not affect bone density, body composition, or psychological measures in postmenopausal women

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2802%2900738-X

7 January 2021

IGF-I deficient mice show reduced peripheral nerve conduction velocities and decreased axonal diameters and respond to exogenous IGF-I treatment

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2802%2900738-X

7 January 2021

Alendronate Induces Antinociception in Mice, Not Related With Its Effects in Bone

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2802%2900738-X

7 January 2021

The insulin-like growth factor system and the coupling of formation to resorption

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2802%2900738-X

7 January 2021

Insulin-like growth factor I stimulates bone turnover in osteoporosis

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2802%2900738-X

7 January 2021

Elevated blood pressure and enhanced myocardial contractility in mice with severe IGF-1 deficiency

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2802%2900738-X

7 January 2021

Studies on the potential mediators of skeletal changes occurring during puberty in girls

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2802%2900738-X

7 January 2021

Comparison of the distribution of 3H-alendronate and 3H-etidronate in rat and mouse bones

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2802%2900738-X

7 January 2021

Effects of recombinant insulin-like growth factor-binding protein-4 on bone formation parameters in mice

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2802%2900738-X

7 January 2021

Insulin-like growth factor-I supports formation and activation of osteoclasts

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2802%2900738-X

7 January 2021

Development of Valid Methods to Measure Insulin-Like Growth Factors-I and -II in Bone Cell-Conditioned Medium*

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2802%2900738-X

7 January 2021

Development, validation, and application of a radioimmunoassay for insulin-like growth factor binding protein-5 in human serum and other biological fluids.

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2802%2900738-X

7 January 2021

The two faces of growth: Benefits and risks to bone integrity

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2802%2900738-X

7 January 2021

https://api.crossref.org/works/10.1016%2FS8756-3282%2802%2900738-X

1 reference

7 January 2021

Postnatal and pubertal skeletal changes contribute predominantly to the differences in peak bone density between C3H/HeJ and C57BL/6J mice

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2802%2900738-X

7 January 2021

Circulating and skeletal insulin-like growth factor-I (IGF-i) concentrations in two inbred strains of mice with different bone mineral densities

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2802%2900738-X

7 January 2021

Intermittent administration of parathyroid hormone (1-37) improves growth and bone mineral density in uremic rats

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2802%2900738-X

7 January 2021

Reduced rates of skeletal remodeling are associated with increased bone mineral density during the development of peak skeletal mass

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2802%2900738-X

7 January 2021

Continuous s.c. infusion rather than twice-daily injections of IGF-I more effectively increases serum IGF binding protein-3 in female monkeys

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2802%2900738-X

7 January 2021

10.1016/S8756-3282(02)00738-X

Identifiers

DOI

1 reference

28 June 2017

1 reference